Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
80 Results Found
Chair File: Leadership Dialogue — The Importance of the 340B Program with Aimee Kuhlman of the AHA and Paulette Davidson of Monument Health
AHA Board Chair Tina Freese Decker talks with AHA VP Aimee Kuhlman and Monument Health CEO Paulette Davidson about the benefits of the 340B program.
Chair File: Protecting 340B and Access to Care
For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients and expand health services to the communities they serve.
HRSA approves 8 drug company plans for participation in 340B Rebate Model Pilot Program
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans
Senate HELP Committee holds hearing on growth, impact of 340B
The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing discussing the 340B program and its growth and impacts on patients.
Rhode Island district court denies drug company efforts to block state’s 340B contract pharmacy law
The U.S. District Court for the District of Rhode Island Sept.
AHA says HRSA vastly underestimates costs 340B Rebate Pilot Program will inflict on hospitals, urges agency to delay implementation
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program
AHA comments on CY 2026 OPPS proposed rule
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical center payment system proposed rule.
Appeals court upholds lower court denial of AbbVie’s preliminary injunction, preserving Mississippi 340B contract pharmacy law
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
AHA urges FTC, DOJ to investigate anticompetitive activity by drug companies on 340B rebate models
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts to impose rebate models within the 340B Drug Pricing Program, saying the actions may violate antitrust laws.